| 1α,25(OH)2D3 | 1α,25-dihydroxy-vitamin D3 |
| ABT | abatacept |
| ACPA | anticitrullinated protein antibody |
| ADA | adalimumab |
| AtoM | arthritis-associated osteoclastogenic macrophages |
| BAR | baricitinib |
| bDMARDs | biological disease-modifying antirheumatic drugs |
| CIA | collagen-induced arthritis |
| csDMARDs | conventional synthetic disease-modifying antirheumatic drugs |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein-4 |
| CZP | certolizumab pegol |
| DC-OC | dendritic cell-derived osteoclast |
| DKK1 | dickkopf1 |
| ETN | etanercept |
| FIL | filgotinib |
| FLS | fibroblast-like synoviocyte |
| Fox | forkhead box protein |
| IFX | infliximab |
| M-CSF | macrophage colony-stimulating factor |
| Mo-OC | monocyte-derived osteoclast |
| mTORC1 | mammalian target of rapamycin complex 1 |
| MTX | methotrexate |
| NFATc1 | nuclear factor of activated T cell c1 |
| OPG | osteoprotegerin |
| PEF | peficitinib |
| RA | rheumatoid arthritis |
| RANK | receptor activator of nuclear factor-κB |
| RANKL | receptor activator of nuclear factor-κB ligand |
| Runx | runt-related transcription factor |
| S1P | sphingosine-1-phosphate |
| SAR | sarilumab |
| sFRP | secreted Frizzled-related protein |
| TCZ | tocilizumab |
| TGF-b | transforming growth factor-beta |
| TNF-a | tumor necrosis factor-alpha |
| TOF | tofacitinib |
| tsDMARDs | targeted synthetic disease-modifying antirheumatic drugs |
| UPA | upadacitinib |
| Wnt | wingless-related MMTV integration site |